JPMORGAN CHASE & CO. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 190 USD | -4.08% |
|
-.--% | +22.03% |
| 06-28 | US court may put off hearing on Citgo bids to September | RE |
| 06-28 | JPMorgan Chase Announces New $30 Billion Share Buyback Program, Plan to Increase Q3 Dividend | MT |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
Ratings chart - Surperformance
Sector: Banks
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +22.03% | 581B | - | ||
| +18.12% | 311B | C+ | ||
| +21.47% | 263B | C+ | ||
| +24.09% | 187B | B- | ||
| +29.19% | 175B | B- | ||
| +7.62% | 158B | C+ | ||
| -1.49% | 154B | B- | ||
| +8.69% | 150B | B- | ||
| +12.55% | 142B | C+ | ||
| +42.84% | 125B | B |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- JPM Stock
- JPM_KZ Stock
- Ratings JPMorgan Chase & Co.
